Cost-effectiveness of norovirus vaccination in children in Peru.

ABSTRACT:

Background

With candidate norovirus (NV) vaccines in a rapid phase of development, assessment of the potential economic value of vaccine implementation will be necessary to aid health officials in vaccine implementation decisions. To date, no evaluations have been performed to evaluate the benefit of adopting NV vaccines for use in the childhood immunization programs of low- and middle-income countries.

Methods

We used a Markov decision model to evaluate the cost-effectiveness of adding a two-dose NV vaccine to Peru's routine childhood immunization schedule using two recent estimates of NV incidence, one for a peri-urban region and one for a jungle region of the country.

Results

Using the peri-urban NV incidence estimate, the annual cost of vaccination would be $13.0

SUBMITTER: Mirelman AJ 

PROVIDER: S-EPMC4461495 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature